Chemoinformaics analysis of 2,6-Dideoxy-2,6-Imino-D-Glycero-L-Gulo-Hepitol
| Molecular Weight | 219.193 | nRot | 1 |
| Heavy Atom Molecular Weight | 206.089 | nRig | 11 |
| Exact Molecular Weight | 219.074 | nRing | 2 |
| Solubility: LogS | -1.313 | nHRing | 2 |
| Solubility: LogP | -1.946 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 27.9403 |
| nHD | 4 | BPOL | 17.3557 |
| QED | 0.381 |
| Synth | 4.211 |
| Natural Product Likeliness | 1.252 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.185 |
| HIA | 0.841 |
| CACO-2 | -5.348 |
| MDCK | 0.00181836 |
| BBB | 0.464 |
| PPB | 0.11005 |
| VDSS | 0.383 |
| FU | 0.85478 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.067 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.223 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.162 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.124 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.021 |
| CL | 1.94 |
| T12 | 0.606 |
| hERG | 0.02 |
| Ames | 0.075 |
| ROA | 0.022 |
| SkinSen | 0.132 |
| Carcinogencity | 0.035 |
| EI | 0.011 |
| Respiratory | 0.023 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.941398 |